{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T05:50:05Z","timestamp":1778133005951,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["DK088945"],"award-info":[{"award-number":["DK088945"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["DK19525"],"award-info":[{"award-number":["DK19525"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["DK050306"],"award-info":[{"award-number":["DK050306"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Research Fund of the National University Hospital of Iceland and from the University of Iceland Research Fund"}],"content-domain":{"domain":["dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.dld.2013.09.021","type":"journal-article","created":{"date-parts":[[2013,11,7]],"date-time":"2013-11-07T01:15:37Z","timestamp":1383786937000},"page":"125-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["The effects of long-term therapy with proton pump inhibitors on meal stimulated gastrin"],"prefix":"10.1016","volume":"46","author":[{"given":"H\u00f3lmfridur","family":"Helgad\u00f3ttir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Metz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Xiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew D.","family":"Rhim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Einar S.","family":"Bj\u00f6rnsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2013.09.021_bib0005","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1053\/j.gastro.2009.03.058","article-title":"Proton-pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy","volume":"137","author":"Reimer","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2013.09.021_bib0010","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1038\/ajg.2010.81","article-title":"Dyspeptic symptom development after discontinuation of a proton pump inhibitor: a double-blind placebo-controlled trial","volume":"105","author":"Niklasson","year":"2010","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2013.09.021_bib0015","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3748\/wjg.v13.i4.493","article-title":"Physiological and clinical significance of enterochromaffin-like cell activation in the regulation of gastric acid secretion","volume":"13","author":"Cui","year":"2007","journal-title":"The World Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2013.09.021_bib0020","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3109\/00365520903477348","article-title":"Rebound acid hypersecretion from a physiological, pathophysiological and clinical viewpoint","volume":"45","author":"Waldum","year":"2010","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2013.09.021_bib0025","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1111\/j.1572-0241.2003.07665.x","article-title":"Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs","volume":"98","author":"Inadomi","year":"2003","journal-title":"The American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2013.09.021_bib0030","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/j.1365-2036.2006.03084.x","article-title":"Discontinuation of proton pump inhibitors in patients on long-term therapy: a double-blind, placebo-controlled trial","volume":"24","author":"Bjornsson","year":"2006","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1016\/j.dld.2013.09.021_bib0035","doi-asserted-by":"crossref","DOI":"10.3109\/00365521.2012.746395","article-title":"Systematic review: symptoms of rebound acid hypersecretion following proton pump inhibitor treatment","author":"Lodrup","year":"2013","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2013.09.021_bib0040","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00004836-200109000-00007","article-title":"Does short-term treatment with proton pump inhibitors cause rebound aggravation of symptoms","volume":"33","author":"Farup","year":"2001","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1016\/j.dld.2013.09.021_bib0045","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3109\/00365521.2010.537684","article-title":"Clinical and pathophysiological consequences of on-demand treatment with PPI in endoscopy-negative reflux disease. Is rebound hypersecretion of acid a problem?","volume":"46","author":"Juul-Hansen","year":"2011","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2013.09.021_bib0050","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1038\/ajg.2011.220","article-title":"Withdrawing PPI therapy after healing esophagitis does not worsen symptoms or cause persistent hypergastrinemia: analysis of dexlansoprazole MR clinical trial data","volume":"106","author":"Metz","year":"2011","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2013.09.021_bib0055","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1053\/j.gastro.2011.01.051","article-title":"The Zollinger-Ellison syndrome and mismeasurement of gastrin","volume":"140","author":"Rehfeld","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2013.09.021_bib0060","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1177\/002215540205001108","article-title":"Chromogranin A in the human gastrointestinal tract: an immunocytochemical study with region-specific antibodies","volume":"50","author":"Portela-Gomes","year":"2002","journal-title":"Journal of Histochemistry & Cytochemistry"},{"key":"10.1016\/j.dld.2013.09.021_bib0065","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/gut.2006.101634","article-title":"Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report","volume":"56","author":"Malfertheiner","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.dld.2013.09.021_bib0070","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1136\/gut.34.6.752","article-title":"Influence of Helicobacter pylori, sex, and age on serum gastrin and pepsinogen concentrations in subjects without symptoms and patients with duodenal ulcers","volume":"34","author":"Mossi","year":"1993","journal-title":"Gut"},{"key":"10.1016\/j.dld.2013.09.021_bib0075","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/00042737-200205000-00008","article-title":"Validated accuracy of a novel urea breath test for rapid Helicobacter pylori detection and in-office analysis","volume":"14","author":"Hegedus","year":"2002","journal-title":"European Journal of Gastroenterology & Hepatology"},{"key":"10.1016\/j.dld.2013.09.021_bib0080","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/BF02349633","article-title":"Detection of Helicobacter pylori DNA in gastric juice by the polymerase chain reaction: comparison with findings in bacterial culture and the detection of tissue IgA and serum IgG antibodies against Helicobacter pylori","volume":"30","author":"Matsukura","year":"1995","journal-title":"The Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2013.09.021_bib0085","series-title":"Statistical methods in medical research","author":"Peter Armitage","year":"2002"},{"key":"10.1016\/j.dld.2013.09.021_bib0090","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/00365521.1974.12096789","article-title":"Radioimmunoassay of gastrin. Fasting serum levels in humans with normal and high gastric acid secreation","volume":"9","author":"Gedde-Dahl","year":"1974","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2013.09.021_bib0095","first-page":"58","article-title":"Serum gastrin concentrations in healthy males and females of various ages","volume":"26","author":"Archimandritis","year":"1979","journal-title":"Acta Hepatogastroenterologica (Stuttg)"},{"key":"10.1016\/j.dld.2013.09.021_bib0100","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/ajg.2009.629","article-title":"Elevated serum gastrin is associated with a history of advanced neoplasia in Barrett's esophagus","volume":"105","author":"Wang","year":"2010","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2013.09.021_bib0105","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1172\/JCI110818","article-title":"Sex-related differences in gastrin release and parietal cell sensitivity to gastrin in healthy human beings","volume":"71","author":"Feldman","year":"1983","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.dld.2013.09.021_bib0110","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1042\/cs0800619","article-title":"Twenty-four hour intragastric acidity and plasma gastrin concentration profiles in female and male subjects","volume":"80","author":"Prewett","year":"1991","journal-title":"Clinical Science (London)"},{"key":"10.1016\/j.dld.2013.09.021_bib0115","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0016-5085(90)90946-X","article-title":"Effect of long-term treatment with omeprazole on serum gastrin and serum group A and C pepsinogens in patients with reflux esophagitis","volume":"99","author":"Jansen","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2013.09.021_bib0125","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2036.2012.05106.x","article-title":"Long-term, open-label trial: safety and efficacy of continuous maintenance treatment with pantoprazole for up to 15 years in severe acid-peptic disease","volume":"36","author":"Brunner","year":"2012","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1016\/j.dld.2013.09.021_bib0130","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.1365-2036.1999.00466.x","article-title":"Serum gastrin and chromogranin A during medium- and long-term acid suppressive therapy: a case-control study","volume":"13","author":"Sanduleanu","year":"1999","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1016\/j.dld.2013.09.021_bib0135","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1136\/gut.39.5.649","article-title":"Marked increase in gastric acid secretory capacity after omeprazole treatment","volume":"39","author":"Waldum","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.dld.2013.09.021_bib0140","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000321535","article-title":"Effect of proton-pump inhibitor therapy on serum chromogranin a level","volume":"84","author":"Pregun","year":"2011","journal-title":"Digestion"},{"key":"10.1016\/j.dld.2013.09.021_bib0145","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1046\/j.1365-2362.2001.00890.x","article-title":"Serum chromogranin A as a screening test for gastric enterochromaffin-like cell hyperplasia during acid-suppressive therapy","volume":"31","author":"Sanduleanu","year":"2001","journal-title":"European Journal of Clinical Investigation"},{"key":"10.1016\/j.dld.2013.09.021_bib0150","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1080\/00365540701225736","article-title":"Seroprevalence of Helicobacter pylori and cagA antibodies in Iceland, Estonia and Sweden","volume":"39","author":"Thjodleifsson","year":"2007","journal-title":"Scandinavian Journal of Infectious Diseases"},{"key":"10.1016\/j.dld.2013.09.021_bib0155","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1046\/j.1365-2036.1999.00460.x","article-title":"Review article: Helicobacter pylori and gastro-oesophageal reflux disease-clinical implications and management","volume":"13","author":"O\u2019Connor","year":"1999","journal-title":"Alimentary Pharmacology & Therapeutics"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S159086581300604X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S159086581300604X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T18:55:57Z","timestamp":1647024957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S159086581300604X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S159086581300604X"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2013.09.021","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of long-term therapy with proton pump inhibitors on meal stimulated gastrin","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2013.09.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}